# Gastroesophageal Reflux Treatment in Scleroderma

> **NCT01878526** · PHASE3 · COMPLETED · sponsor: **Khon Kaen University** · enrollment: 80 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease
- Systemic Sclerosis
- Scleroderma

## Interventions

- **DRUG:** Alginic acid
- **DRUG:** placebo (for domperidone)
- **DRUG:** Domperidone
- **DRUG:** placebo (of alginic acid)

## Key facts

- **NCT ID:** NCT01878526
- **Lead sponsor:** Khon Kaen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-08
- **Final completion:** 2016-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01878526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01878526, "Gastroesophageal Reflux Treatment in Scleroderma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01878526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*